Morgan Stanley
CRNC icon

Morgan Stanley’s Cerence CRNC Stock Holding History

Morgan Stanley’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.11M Buy
716,669
+313,288
+78% +$3.07M ﹤0.01% 3873
2026
Q1 		$2.55M Sell
403,381
-321,197
-44% -$2.89M ﹤0.01% 4591
2025
Q4 		$7.75M Buy
724,578
+235,210
+48% +$2.58M ﹤0.01% 3840
2025
Q3 		$6.1M Sell
489,368
-176,282
-26% -$1.81M ﹤0.01% 3991
2025
Q2 		$6.8M Sell
665,650
-363,940
-35% -$3.2M ﹤0.01% 3801
2025
Q1 		$8.13M Buy
1,029,590
+184,912
+22% +$2.28M ﹤0.01% 3530
2024
Q4 		$6.63M Buy
844,678
+218,841
+35% +$1.1M ﹤0.01% 3754
2024
Q3 		$1.97M Sell
625,837
-61,462
-9% -$181K ﹤0.01% 4663
2024
Q2 		$1.95M Buy
687,299
+253,370
+58% +$1.81M ﹤0.01% 4589
2024
Q1 		$6.83M Sell
433,929
-197,883
-31% -$3.35M ﹤0.01% 3657
2023
Q4 		$12.4M Buy
631,812
+155,946
+33% +$2.71M ﹤0.01% 3140
2023
Q3 		$9.69M Sell
475,866
-75,998
-14% -$1.91M ﹤0.01% 3151
2023
Q2 		$16.1M Sell
551,864
-11,192
-2% -$307K ﹤0.01% 2695
2023
Q1 		$15.8M Sell
563,056
-270,874
-32% -$6.95M ﹤0.01% 2685
2022
Q4 		$15.5M Sell
833,930
-7,313
-0.9% -$125K ﹤0.01% 2599
2022
Q3 		$13.2M Buy
841,243
+4,729
+0.6% +$106K ﹤0.01% 2657
2022
Q2 		$21.1M Sell
836,514
-98,539
-11% -$2.95M ﹤0.01% 2233
2022
Q1 		$33.8M Buy
935,053
+768,615
+462% +$37.8M ﹤0.01% 1594
2021
Q4 		$12.8M Sell
166,438
-128,543
-44% -$11.3M ﹤0.01% 2660
2021
Q3 		$28.4M Sell
294,981
-40,154
-12% -$4.38M ﹤0.01% 1734
2021
Q2 		$35.8M Sell
335,135
-21,515
-6% -$2.12M ﹤0.01% 1582
2021
Q1 		$31.9M Buy
356,650
+15,942
+5% +$1.75M ﹤0.01% 1519
2020
Q4 		$34.2M Buy
340,708
+222,575
+188% +$16.6M 0.01% 1378
2020
Q3 		$5.78M Sell
118,133
-85,145
-42% -$4.09M ﹤0.01% 2575
2020
Q2 		$8.3M Buy
203,278
+156,443
+334% +$4.49M ﹤0.01% 2135
2020
Q1 		$722K Sell
46,835
-438
-0.9% -$9.21K ﹤0.01% 4161
2019
Q4 		$1.07M Buy
+47,273
New +$775K ﹤0.01% 4491

Other funds holding CRNC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
ACM
American Capital Management New York $2.23B AUM 28.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NSGL
No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $310M AUM 45.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Morgan Stanley's CRNC Position: Q2 2026 in Review

Morgan Stanley increased its Cerence (CRNC) stake by 78% in Q2 2026, buying an estimated $3.07M and bringing the position to 716,669 shares worth $8.11M. The position accounts for ﹤0.01% of the portfolio, ranked #3873.

Morgan Stanley first reported a position in CRNC in Q4 2019 and has held it in 27 quarters since. The position peaked at $35.8M in Q2 2021. 196 funds tracked by Wall St. Rank hold CRNC as of Q2 2026.

  • Morgan Stanley held 716,669 shares of Cerence worth $8.11M as of Q2 2026.
  • Morgan Stanley bought 313,288 Cerence shares in Q2 2026, an estimated $3.07M.
  • Cerence made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #3873 holding.
  • Morgan Stanley first reported a position in Cerence in Q4 2019 and has held it in 27 quarters since.
  • Morgan Stanley's Cerence position peaked at $35.8M in Q2 2021.
  • 196 funds tracked by Wall St. Rank held Cerence as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.